Marker Therapeutics, Inc. Quarterly Depreciation in USD from Q2 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Marker Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q2 2011 to Q1 2023.
  • Marker Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $800K, a 33.3% increase year-over-year.
  • Marker Therapeutics, Inc. Depreciation for the twelve months ending March 31, 2023 was $800K, a 63.6% decline year-over-year.
  • Marker Therapeutics, Inc. annual Depreciation for 2022 was $600K, a 71.4% decline from 2021.
  • Marker Therapeutics, Inc. annual Depreciation for 2021 was $2.1M, a 320% increase from 2020.
  • Marker Therapeutics, Inc. annual Depreciation for 2020 was $500K, a 400% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $800K $800K +$200K +33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $600K -$1.4M -$1.9M -380% Oct 1, 2022 Dec 31, 2022 10-Q 2023-05-15
Q3 2022 $2.5M $800K +$200K +33.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.3M $600K +$100K +20% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.2M $600K +$100K +20% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $2.1M $500K +$230K +85.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $1.87M $600K +$500K +500% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.37M $500K +$400K +400% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $970K $500K +$470K +1567% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $500K $270K +$240K +800% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $260K $100K +$70K +233% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $190K $100K +$71K +245% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $119K $30K +$19K +173% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $100K $30K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $30K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $29K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $11K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
Q2 2012 $0 $0 Apr 1, 2012 Jun 30, 2012 10-Q/A 2012-09-12
Q2 2011 $0 Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.